Department of Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Eastern Point Road, Groton, CT, 06340, USA.
Ann Clin Biochem. 2010 Jul;47(Pt 4):350-7. doi: 10.1258/acb.2010.010027.
The existing methods for quantitative analysis of free corticosteroids require high volume of plasma and laborious extraction processes. Development of ultrafiltration followed by the liquid chromatrography tandem mass spectrometry (LC-MS/MS) method that requires 300 microL of plasma, does not entail any offline extraction and achieves good sensitivity was described.
Unbound corticosteroids were separated by the ultrafiltration of plasma using Microcon centrifugal filter devices (10,000 Dal nominal molecular weight limit). A 30 microL aliquot of the ultrafiltrate was directly injected into a two-dimensional high-performance liquid chromatography clean-up and separation system coupled with API-4000 mass spectrometer. The clean-up was performed on a Strata-X on-line extraction cartridge. A Zorbax-SB Phenyl, Rapid Resolution HT (2.1 x 100 mm) column was employed to chromatographically resolve cortisol and prednisolone from each other, from cortisone and prednisone as well as from interferences found in plasma from stable kidney transplant recipients.
Intra- and inter-run imprecision and inaccuracy within +/-15% were achieved during a three-batch validation for quality control samples at six concentrations in ultrafiltrate from charcoal-stripped plasma and three concentrations from normal plasma, over a 2000-fold dynamic range. The lower limit of quantification was 0.100 ng/mL for all four corticosteroids.
A highly selective, sensitive, simple and robust LC-MS/MS method was developed for the simultaneous quantification of free cortisol, cortisone, prednisolone and prednisone. The performance of the Strata-X on-line extraction cartridge was maintained for over 700 injections. The assay was successfully applied for the analysis of the analytes in over 500 plasma samples from stable kidney transplant recipients.
现有的游离皮质甾类激素定量分析方法需要大量的血浆和繁琐的提取过程。我们描述了一种超滤液后紧接着进行液相色谱串联质谱(LC-MS/MS)分析的方法,该方法仅需要 300 μL 血浆,无需任何离线提取,且具有良好的灵敏度。
采用 Microcon 离心超滤装置(10000 道尔顿名义分子量限制)对血浆中的未结合皮质甾类激素进行超滤分离。将 30 μL 超滤滤液直接注入二维高效液相色谱净化和分离系统,与 API-4000 质谱仪联用。净化在 Strata-X 在线萃取柱上进行。采用 Zorbax-SB Phenyl、Rapid Resolution HT(2.1×100mm)柱对皮质醇和泼尼松龙进行彼此之间、与皮质酮和泼尼松之间以及从稳定肾移植受者血浆中发现的干扰物质进行色谱分离。
在对经过炭吸附处理的血浆中超滤滤液中的 6 个质控样本浓度和正常血浆中的 3 个浓度进行三批验证期间,在 2000 倍动态范围内,质量控制样品的批内和批间精密度和准确度均在正负 15% 以内。所有四种皮质甾类激素的定量下限均为 0.100ng/mL。
建立了一种高度选择性、灵敏、简单和稳健的 LC-MS/MS 方法,用于同时定量分析游离皮质醇、皮质酮、泼尼松龙和泼尼松。Strata-X 在线萃取柱的性能保持稳定,可进行超过 700 次注射。该方法成功应用于 500 多个稳定肾移植受者的血浆样本中分析这些分析物。